Optum guides providers through important upcoming formulary updates
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
July 23, 2021 - The FDA approved Sun Pharmaceutical’s Drizalma Sprinkle (duloxetine delayed-release), for the treatment of fibromyalgia in adults.
Download PDF
Return to publications
